IFNL3 and cholesteryl ester measurement: In this study, we demonstrated that rAd-mIL-28B can decrease the frequency of Treg and inhibit of Th2 cell activation in E. granulosus infection model, suggesting that IL-28B may be a useful therapeutic agent for CE.